Results 101 to 110 of about 99,547,245 (298)
A carrier‐free peptide‐guided PSP@IR‐CF3 nanofiber system integrates PD‐L1 targeting and photothermal immunotherapy for enhanced cancer treatment. By revealing PTIT‐induced activation of the HSP70/AKT/mTOR pathway and incorporating mTOR inhibition, this strategy effectively overcomes therapeutic resistance and prevents tumor recurrence, providing a ...
Xinyu Zhang +11 more
wiley +1 more source
CTLA-4 expression on tregs is needed for suppression of autoimmune uveitis
Uveitis is a leading cause of blindness in the world and autoimmune uveitis is an ocular tissue specific autoimmune disease. Utilizing experimental autoimmune uveitis (EAU), we can interrogate different immune responses in the mouse that are relevant to ...
Minjun Ahn +3 more
doaj +1 more source
18F‐FGln PET/CT imaging serves as a marker of Gln uptake in hepatocellular carcinoma. Tumors with high Gln uptake drive Treg‐mediated immunosuppression and immune evasion during antitumor immunotherapy. Conversely, tumors with low Gln uptake maintain sufficient Gln in the TME, suppressing Tregs and enabling cytotoxic T cells to inhibit tumor growth ...
Yi Liu +8 more
wiley +1 more source
Alveolar echinococcosis (AE) is a zoonotic parasitic disease caused by the infection of Echinococcus multilocularis (E. multilocularis) larvae. Cytotoxic T-lymphocyte antigen 4 (CTLA-4) produces inhibitory signals and induces T cell exhaustion, thereby ...
Yuxuan Yang +8 more
doaj +1 more source
Results of immunotherapy trials targeting co inhibitory receptors on T cells show that interfering with suppressive pathways can trigger antitumor activity even at advanced disease stages [1]. Proof has been obtained in Phase III trials that treatment with antibodies blocking CTLA-4 extends survival of metastatic melanoma patients.
Demaria, S, Dustin, M
openaire +3 more sources
T cells, the Next Big Target in Axial Spondyloarthritis?
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease characterized by complex immune dysregulation, with T cells playing a central role in its pathogenesis. In this review, we synthesize current knowledge on diverse T cell subsets in axSpA, their pathogenic mechanisms, and emerging therapeutic strategies targeting these cells. We highlight
Mansi K. Aparnathi, Nigil Haroon
wiley +1 more source
Antitumor Responses of Anti-CTLA-4 and Anti-PD-1 Antibodies in Staged MC38 and CT26 Tumor Models.
A-B. Groups of 8–12 C57/BL6 mice were sourced from Taconic and subcutaneously injected with 2×106 MC38 cells. After tumors were measured on day 7, mice were randomized (58 mm3 mean tumor volume per group) and then treated with the designated mAb (200 μg ...
Mark J. Selby (3110964) +13 more
core +1 more source
Objective Somatic DNMT3A mutations are the most common drivers of clonal hematopoiesis in patients with rheumatoid arthritis (RA) and have been associated with seropositive disease and increased markers of inflammation. These mutations are predominantly hypomorphic or dominant‐negative, reducing DNMT3A function.
Yunbing Shen +10 more
wiley +1 more source
The cytoplasmic tail of CTLA-4 is dispensable for Nef-induced CTLA-4 down-regulation.
a) Accumulation of CTLA-4 on the cell surface after transfection with CTLA-4 Y201AY218G and CTLA-4ΔCT mutants and lower expression after transfection with CTLA-4 LL181AA. Black solid histograms represent the isotype controls.
Rabih Halwani (287270) +14 more
core +1 more source
CTLA-4 blockade increases the induction of LCMV gp33specific CTLs and lysis of target cells
Copyright information:Taken from "CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion"http://www.jibtherapies.com/content/5/1/9Journal of Immune Based Therapies and Vaccines 2007;5():9-9 ...
Franca Ronchese (78627) +1 more
core +1 more source

